Molecular pathogenesis of ovarian clear cell carcinoma

被引：31

作者：

Gounaris, Ioannis ^{[1
]}

Brenton, James D. ^{[1
]}

机构：

[1] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 09期

关键词：

ARID1A; endometriosis; genetically engineered mouse models; glycogen; HNF1B; ovarian clear; PIK3CA cell cancer; IDENTIFIES FREQUENT MUTATION; ARID1A PROTEIN EXPRESSION; SWI/SNF-RELATED COMPLEXES; HYPOXIA-INDUCIBLE FACTOR; REMODELING GENE ARID1A; ENDOMETRIAL CANCER; THERAPEUTIC TARGET; GLYCOGEN-SYNTHESIS; TUMOR-SUPPRESSOR; PTEN EXPRESSION;

D O I：

10.2217/fon.15.45

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian clear cell carcinoma is a distinct subtype of epithelial ovarian cancer, characterized by an association with endometriosis, glycogen accumulation and resistance to chemotherapy. Key driver events, including ARID1A mutations and HNF1B overexpression, have been recently identified and their functional characterization is ongoing. Additionally, the role of glycogen in promoting the malignant phenotype is coming under scrutiny. Appreciation of the notion that ovarian clear cell carcinoma is essentially an ectopic uterine cancer will hopefully lead to improved animal models of the disease, in turn paving the way for effective treatments.

引用

页码：1389 / 1405

页数：17

共 137 条

[1] PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma [J].

Abe, Azusa ;

Minaguchi, Takeo ;

Ochi, Hiroyuki ;

Onuki, Mamiko ;

Okada, Satoshi ;

Matsumoto, Koji ;

Satoh, Toyomi ;

Oki, Akinori ;

Yoshikawa, Hiroyuki .

HUMAN PATHOLOGY, 2013, 44 (02) :199-207

[2] Physiological Control of Liver Glycogen Metabolism: Lessons from Novel Glycogen Phosphorylase Inhibitors [J].

Agius, L. .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (12) :1175-1187

[3] The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation [J].

Ali, A. Y. ;

Abedini, M. R. ;

Tsang, B. K. .

ONCOGENE, 2012, 31 (17) :2175-2186

[4]

Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]

[5] IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer [J].

Anglesio, Michael S. ;

George, Joshy ;

Kulbe, Hagen ;

Friedlander, Michael ;

Rischin, Danny ;

Lemech, Charlotte ;

Power, Jeremy ;

Coward, Jermaine ;

Cowin, Prue A. ;

House, Colin M. ;

Chakravarty, Probir ;

Gorringe, Kylie L. ;

Campbell, Ian G. ;

Okamoto, Aikou ;

Birrer, Michael J. ;

Huntsman, David G. ;

de Fazio, Anna ;

Kalloger, Steve E. ;

Balkwill, Frances ;

Gilks, C. Blake ;

Bowtell, David D. .

CLINICAL CANCER RESEARCH, 2011, 17 (08) :2538-2548

[6] Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010 [J].

Anglesio, Michael S. ;

Carey, Mark S. ;

Koebel, Martin ;

MacKay, Helen ;

Huntsman, David G. .

GYNECOLOGIC ONCOLOGY, 2011, 121 (02) :407-415

[7]

[Anonymous], 15 BIENN M INT GYN C

[8]

[Anonymous], 2014, ANN ONCOL

[9]

[Anonymous], HUM PATHOL

[10] Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma [J].

Ayhan, Ayse ;

Mao, Tsui-Lien ;

Seckin, Tamer ;

Wu, Chen-Hsuan ;

Guan, Bin ;

Ogawa, Hiroshi ;

Futagami, Masayuki ;

Mizukami, Hiroki ;

Yokoyama, Yoshihito ;

Kurman, Robert J. ;

Shih, Ie-Ming .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) :1310-1315

← 1 2 3 4 5 6 7 8 9 10 →